Company profile for Odonate Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. We are a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class o...
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. We are a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Diego, CA 92121
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20220107005100/en

BUSINESSWIRE
07 Jan 2022

https://www.businesswire.com/news/home/20211117005445/en

BUSINESSWIRE
17 Nov 2021

https://www.businesswire.com/news/home/20211110005549/en/Odonate-Therapeutics-Announces-Financial-Results-for-the-Three-and-Nine-Months-Ended-September-30-2021

BUSINESSWIRE
10 Nov 2021

https://www.businesswire.com/news/home/20210727005343/en

PR NEWSWIRE
27 Jul 2021
Odonate abandons breast cancer chemo drug, closes its doors
Odonate abandons breast cancer chemo drug, closes its doors

23 Mar 2021

// A. Al Idrus FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/odonate-abandons-breast-cancer-chemo-drug-closes-its-doors

A. Al Idrus FIERCE BIOTECH
23 Mar 2021

https://endpts.com/those-nda-plans-odonate-had-for-mid-21-theyre-being-scrapped-along-with-the-entire-biotech-in-a-sudden-implosion/

John Carroll ENDPTS
22 Mar 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty